1964
DOI: 10.1016/s0140-6736(64)90737-8
|View full text |Cite
|
Sign up to set email alerts
|

Low in-Vivo Adhesive-Platelet Count in Hereditary Hæmorrhagic Telangiectasia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
7
0
5

Year Published

1966
1966
1998
1998

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(12 citation statements)
references
References 10 publications
0
7
0
5
Order By: Relevance
“…The various abnormalities in in vitro platelet function published in the literature by several authors [12][13][14][15] have not been found neither by us nor by others [16]. No quantitative abnormali ties in von Willebrand factor ristocetin cofactor activ ity suggesting a possible von Willebrand disease could be demonstrated, although some groups have evidenced the coexistence of both pathologies in several members from a single kindred [17,18].…”
Section: Discussionmentioning
confidence: 71%
See 2 more Smart Citations
“…The various abnormalities in in vitro platelet function published in the literature by several authors [12][13][14][15] have not been found neither by us nor by others [16]. No quantitative abnormali ties in von Willebrand factor ristocetin cofactor activ ity suggesting a possible von Willebrand disease could be demonstrated, although some groups have evidenced the coexistence of both pathologies in several members from a single kindred [17,18].…”
Section: Discussionmentioning
confidence: 71%
“…Although the severity of bleeding is highly variable from one patient to another, in some patients, the frequent and continuous requirement of red blood cell transfusions occasionally leads to the development of secondary effects from chronic blood administration [2], No ef fective therapy has been found to stop or, at least, to lessen recurrent bleeding [2,26,27], Fragility of the vessel wall was firstly implicated in the bleeding tendency of these patients [9] but more recently, alterations in platelet function [12][13][14][15], asso ciation between HHT and von Willebrand's disease [17,18] and analytical evidence of compensated dis seminated intravascular coagulation syndrome [10], have been considered in the pathophysiology of this disorder. Fibrinolytic activators have also been impli cated in it [11].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Patients with von Willebrand's disease have long bleeding times, diminished platelet adhesiveness following addition of minute amounts of ADP to platelet-rich plasma, and diminished platelet adhesiveness in whole blood (Salzman, 1963 ;Hellem and Owren, 1964;Muckle, 1964). Thrombasthenic patients and some patients with hcrcditary hacinorrhagic telangiectasia also have prolonged bleeding times and very low adhesive platelet counts (Salznian, 1963 ;Hellem and Owren, 1964;Muckle, 1964).…”
Section: Discussionmentioning
confidence: 99%
“…Both AVM and telangiectasia are surrounded by a cuff of fibrous tissue which prevents vessel contraction following injury, and which promotes the hemorrhagic manifestations of the disease [22]. In addition to the obvious vascular malformations, patients with HHT also have abnormalities of blood coagulation, including the presence of von Willebrand factor (vWF), and factor VIII deficiency, as well as defects of fibrinolysis and platelet function [24][25][26][27][28][29]. These may further affect the severity and the chronicity of bleeding.…”
mentioning
confidence: 99%